BDBM590773 4-hydroxy-6-(4-methoxyphenyl)-N-(4- methylcyclohexyl)-1-(2-morpholinoethyl)-2-oxo- 1,2-dihydro-1,8-naphthyridine-3-carboxamide::US11564928, Compound 20

SMILES COc1ccc(cc1)-c1cnc2n(CCN3CCOCC3)c(=O)c(C(=O)NC3CCC(C)CC3)c(O)c2c1

InChI Key InChIKey=BRQMMGCZMHEFIJ-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 590773   

TargetCannabinoid receptor 2(Human)
Teon Therapeutics

US Patent
LigandPNGBDBM590773(US11564928, Compound 20 | 4-hydroxy-6-(4-methoxyph...)
Affinity DataIC50: 4.70nMAssay Description:CB1R binding protocol involves the use of the same solution buffer used for both incubation and washing reaction (Tris-HCl, 50 mM; EDTA, 2.5 mM; MgCl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
US Patent

TargetCannabinoid receptor 1(Human)
Teon Therapeutics

US Patent
LigandPNGBDBM590773(US11564928, Compound 20 | 4-hydroxy-6-(4-methoxyph...)
Affinity DataIC50: 1.00E+4nMAssay Description:CB1R binding protocol involves the use of the same solution buffer used for both incubation and washing reaction (Tris-HCl, 50 mM; EDTA, 2.5 mM; MgCl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
US Patent